for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Tianjin Zhongxin Phrmctl Gp Cp Ltd

600329.SS

Latest Trade

14.14CNY

Change

-0.24(-1.67%)

Volume

2,464,069

Today's Range

14.03

 - 

14.35

52 Week Range

11.80

 - 

18.16

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14.38
Open
14.35
Volume
2,464,069
3M AVG Volume
79.64
Today's High
14.35
Today's Low
14.03
52 Week High
18.16
52 Week Low
11.80
Shares Out (MIL)
768.87
Market Cap (MIL)
12,205.93
Forward P/E
15.63
Dividend (Yield %)
1.53

Next Event

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Annual Shareholders Meeting

Latest Developments

More

Tianjin Zhongxin Pharmaceutical Group Posts Qtrly Revenue RMB1.75 Bln Vs RMB1.62 Bln

Tianjin Zhongxin Pharmaceutical Group Corp Says Yan Min Ceases To Be CFO

Tianjin Zhongxin Pharmaceutical Group Posts Q3 Profit Attributable Of RMB87.4 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Tianjin Zhongxin Phrmctl Gp Cp Ltd

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company principally engaged in the manufacturing and sales of pharmaceuticals. The Company's principal businesses include the research, development and manufacture of Chinese patent medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine and nutraceuticals, as well as the distribution of pharmaceuticals. The Company's main products include cardiovascular and respiratory medicines, gastrointestinal drugs and anti-cancer drugs.

Industry

Major Drugs

Contact Info

No. 17, Baidi Road, Nankai District

+86.22.27020892

http://www.zhongxinp.com/

Executive Leadership

Zhiqiang Wang

Chairman of the Board, General Manager

Jun Sun

Chief Accounting Officer, Deputy General Manager, Director

Daoqing Xu

Deputy General Manager, Chief Engineer, Director

Jian Zhang

Deputy General Manager

Lei Wang

Executive Director

Key Stats

1.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

6.2K

2017

5.7K

2018

6.4K

2019(E)

7.0K
EPS (CNY)

2016

0.550

2018

0.730

2019(E)

0.920
Price To Earnings (TTM)
18.60
Price To Sales (TTM)
1.80
Price To Book (MRQ)
2.16
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
1.29
LT Debt To Equity (MRQ)
0.07
Return on Investment (TTM)
12.12
Return on Equity (TTM)
8.31

Latest News

BRIEF-Tianjin Zhongxin Pharma's H1 net profit up 7.3 pct y/y

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

BRIEF-Tianjin Zhongxin Pharma's 2016 net profit down 6.4 pct y/y

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up